advertisement

WGA Rescources

Greenfield DS 10

Showing records 1 to 10 | Display all abstracts from Greenfield DS

104306 Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy
Islam YFK
Journal of Glaucoma 2022; 31: 744-750
104776 Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial
Feldman RM; Chuang AZ
Journal of Glaucoma 2022; 31: 701-709
104306 Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy
Vanner EA
Journal of Glaucoma 2022; 31: 744-750
104776 Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial
Mansberger SL
Journal of Glaucoma 2022; 31: 701-709
104306 Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy
Khurshid SG
Journal of Glaucoma 2022; 31: 744-750
104776 Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial
Tanna AP
Journal of Glaucoma 2022; 31: 701-709
104306 Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy
Flynn HW
Journal of Glaucoma 2022; 31: 744-750
104776 Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial
Blieden LS
Journal of Glaucoma 2022; 31: 701-709
104306 Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy
Greenfield DS
Journal of Glaucoma 2022; 31: 744-750
104776 Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial
Bell NP; Gross RL; Pasquale LR; Greenfield DS; Liebmann JM; Weinreb RN;
Journal of Glaucoma 2022; 31: 701-709

Issue 23-2

Change Issue


advertisement

Oculus